Monoclonal Anti-DDX53 Antibody

Human Protein Atlas
Recommended conditions:
Working concentration: 1 µg/ml
Validated in Western blot using relevant lysates (see Western blot application images above)
miR-429 Suppresses Endometrial Cancer Progression and Drug Resistance via DDX53
J Pers Med , 2023 Aug 25; 13(9):1302. Epub 2023 Aug 25
Did we miss your publication?
Have you published using AMAb91489? Please let us know and we will be happy to include your reference on this page.
Join the Explorer Program
Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers a 25µl vial free of charge with your next order.
Questions?
Our customer support and expert scientific support teams are here to help you succeed in your research.